Astrana Health (ASTH) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
27 Aug, 2026Market context and challenges
U.S. healthcare is fragmented, costly, and delivers poor access and satisfaction for both patients and providers.
Administrative complexity and limited technology hinder coordinated care and efficiency.
Business model and operating platform
Implements a delegated financial model, aligning incentives across payers, providers, and patients for better outcomes and cost control.
AI-native operating platform integrates data, automates workflows, and supports clinical decision-making at scale.
Model enables providers to partner across all payer types, reducing administrative burden and improving care coordination.
Growth and geographic expansion
Expanded from a single market to 16 markets nationwide between 2019 and 2025.
Scaled provider network to over 20,000 with 1.55 million members in value-based arrangements as of Q1 2026.
Latest events from Astrana Health
- Record Q3 growth and maintained FY26 guidance amid Medicaid and cybersecurity risks.ASTH
Q3 2026 - FY 2023 revenue rose 21%; 2024 guidance targets $1.65B–$1.85B.ASTH
Q4 2023 - AI-driven platform and delegated risk model drive growth, efficiency, and improved outcomes.ASTH
Investor presentation - Q2 2026 revenue up 49%, net income more than doubled, and guidance was raised.ASTH
Q2 2026 - Rapid growth, tech-driven efficiencies, and resilient margins amid regulatory shifts.ASTH
Bank of America Global Healthcare Conference 2026 - Q3 revenue up 37% to $478.7M; guidance raised after major acquisitions and capitation growth.ASTH
Q3 2024 - $745M deal expands reach to 1.7M members, with $12M in synergies targeted by 2027.ASTH
M&A Announcement - Q1 revenue up 53% to $620.4M, but profitability declined; 2025 outlook remains robust.ASTH
Q1 2025 - 2024 revenue rose 47% to $2.03B, with Adjusted EBITDA up 16% to $170.4M.ASTH
Q4 2024